Johnson & Johnson (USD)
JNJ
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range144.35 | 147.47
52-Wk Range- | -
Last Close145.24
Mkt Cap (m)382,391.28
Dividend yield2.70
ISINUS4781601046
Volume4,154,372.00
Exchange VenueNYS

Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Key Information
Price/Earning22.84
Price/Book6.07
Price/Sales4.80
P/CF18.71
Rev Growth (3 year avg)4.51
EPS Growth (3 year avg)-0.02
Operating Margin % 24.47
Net Margin %18.42
Return on Equity25.36
Debt/Equity0.47

Documents

Prospectus
en 24/08/2020
Annual Report
en 29/12/2019

Please refer to the below issuer website for further documents.

http://www.jnj.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)74,331.0070,074.0071,890.0076,450.0081,581.0082,059.00
Operating Income (m)20,959.0018,065.0021,136.0018,714.0020,049.0020,080.00
Net Income (m)16,323.0015,409.0016,540.001,300.0015,297.0015,119.00
Basic EPS5.805.566.040.485.705.72
Avg. Diluted Shares Outstanding (m)2,863.902,812.902,788.902,745.302,728.702,684.30
Balance Sheet
USD201420152016201720182019
Current Assets (m)59,311.0060,210.0065,032.0043,088.0046,033.0045,274.00
Non Current Assets (m)71,808.0073,201.0076,176.00114,215.00106,921.00112,454.00
Total Assets (m)131,119.00133,411.00141,208.00157,303.00152,954.00157,728.00
Current Liabilities (m)25,085.0027,747.0026,287.0030,537.0031,230.0035,964.00
Total Liabilities (m)------
Total Equity (m)69,752.0071,150.0070,418.0060,160.0059,752.0059,471.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)18,471.0019,279.0018,767.0021,056.0022,201.0023,416.00
Capital Expenditure (m)-3,714.00-3,463.00-3,226.00-3,279.00-3,670.00-3,498.00
Figures are quoted in USD unless stated otherwise
-
No change
$
145.24
Last Price